UGNE receives Swiss pre-approval for Forcaltonin

Unigene Laboratories (UGNE) received a pre-approval letter from Switzerland indicating that the country intends to approve UGNE's injectable recombinant calcitonin product, Forcaltonin, to treat osteo...